• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

Molecular analysis of anti-inflammatory effect of IL-10 and IL-4 on monocytes and neutrophils.

Research Project

Project/Area Number 09671120
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionKyushu University

Principal Investigator

OTSUKA Takeshi  Kyushu University, Faculty of Medicine, assistant professor, 医学部, 助手 (50213773)

Co-Investigator(Kenkyū-buntansha) IZUHARA Kenji  Kyushu University, Faculty of Medicine, assistant professor, 医学部, 助手 (00270463)
TANAKA Yosuke  Kyushu University, 医学部, 医員
YAMAOKA Kunihiro  Kyushu University, 医学部, 医員
NIIRO Hiroaki  Kyushu University, 医学部, 特別研究員
NAKASHIMA Hitoshi  Kyushu University, Faculty of Medicine, assistant professor, 医学部, 助手 (70188960)
Project Period (FY) 1997 – 1998
Keywordsmacrophage / neutrophil / interleukin-4 / interleukin-10 / cyclooxygenase / JAK-STAT / signal transduction
Research Abstract

1) We investigated the effects of IL-4 and IL-1 on prostanoid synthesis in human neutrophils. Both cytokines inhibited their LPS-induced-PGE2 production, and their suppression was achieved by inhibiting cyclooxygense-2 mRNA expression. (Ref. 1)
2) We previously reported that IL-4 and IL-l0 suppressed prostanoid synthesis in human monocytes.
We questioned whether mitogen-activated protein kinase (MAPK) activation is involved in COX-2 expression in LPS-stimulated human monocytes. LPS induced the expression of COX-2 protein and COX-2 mRNA as well as the phospholylation and activation of extracellular signal-regulated protein kinase (ERK)2 and p38 MAPK in monocytes. The induction of COX-2 mRNA, COX-2 protein, and prostaglandin (PG) E2 by LPS was inhibited by the specific inhibitors of ERK2 and p38 MAPK.LPS-induced phosphorylation and activation of ERK2 was significantly inhibited by IL-4 and IL-10, while that of p38 MAPK was inhibited by IL-10, but not IL-4. These results suggested that the … More mechanisms of inhibition by IL-l0 and IL-4 of the LPS-induced expression of proinflammatory molecules could be ascribed to the regulatory effects of both cytokines on MAPK activation. (Ref. 2)
3) We also studied whether some known STAT molecule is stimulated by LPS, based on the finding that a GAS motif sequence is conserved in the promoter regions of human, mouse, and rat COX-2 genes.
Consequently, LPS induced activation of STAT5 in human monocytes, and this STATS activation occured in an indirect way via granulocyte-macrophage colony stimulating factor secreted by LPS- stimulated monocytes.Expression of COX-2 protein was partially reduced by treatment of anti-human GM-CSF Ab, Activation of STAT5 wa inhibited by either IL-10 or dexamethazone, but not by aspirin.IL-10 blocked activation of STATS indirectly by suppressing GM-CSF production, while Dex inhibited this activation both directly and indirectly.These results suggested that STAT5 plays an important role in activation of monocytes by LPS, and that STAT5 is another target for IL-10 and Dex to inhibit COX-2 expression. (Ref. 3)
4) In rheumatoid arthritis patients, polymorphonuclear leukocytes are an important cellular source of prostanoids. To determine whether PMNs from RA patients exhibit different profiles in prostanoid synthesis compared to those from healthy donors, we studied 20 RA patients. Without stimulation, PGE2 production by PMNs was much higher in the RA patients than in the healthy controls. COX-2 protein was thought to be responsible for this increased PGE2 production. Neither IL-4 nor IL-10 affected the production. In conclusion, our results raise the possibility that PMNs from RA patients contribute, at least in part, to the pathogenesis of RA by producing COX-2-derived prostanoids in vivo. (Ref. 4)
5) Since IL-10 was thought involved in pathogenesis of human diseases, we examined polymorphisms within human. IL-10 receptor cDNA gene sequenceby RT-PCR-RFLP.(Ref. 5) We further plan to examine the sensitivity of these polymorphisms for various immune disease. Less

  • Research Products

    (35 results)

All Other

All Publications (35 results)

  • [Publications] Gao PS: "Variants of IFNgR1 and IFNgR2 in atopic asthma." Hum.Genet. 印刷中.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Arinobu Y: "Antagonistic effects of an alternative splice variant of human IL-R,IL-4d2,on IL-4 activities in human monocytes and B cells." Cellular Immunology. 印刷中.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tanaka Y: "Association of the interferon-g receptor variant (Val14Met)with Systemic Lupus Erythematodes." Immunogenetics. 印刷中.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nagano S: "Increased constitutive PGE2 production by polymorphonuclear leukocytes in rheumatoid arthritis." Proceedings of the 10th International Congress of Immunology. 983-987 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Otsuka T: "Growth inhibition of leukemic cells by (-)-epigallocatechin gallate," Life Sciences. 1397-1403 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Niiro H: "MAP kinase pathways as a route for regulatory mechanisms IL-10 and IL-4 which inhibit COX-2 expression in human monocytes." Biochem Biophys Res Commun. 250(2). 200-205 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Niho Y: "Role of IL-10 in the crossregulation of prostaglandins and cytokines in monocytes." Acta Haematol. 99. 165-170 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaoka K: "Activation of STAT5 by LPS through GM-CSF production in human monocytes." J.Immunol. 160(2). 838-845 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tanaka Y: "Detection of polymorphisms within human IL-10 receptor cDNA gene sequence by RT-PCR-RFLP." Immunogenetics. 46. 439-441 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 永淵正法: "慢性活動性Epstein-Barrウイルス感染症の免疫不全と発癌" 感染症学雑誌. 71(1). 56-64 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Asano Y: "Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia." Life Sciences. 60(2). 135-142 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Niiro H: "Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils." Blood. 89(5). 1621-1628 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大塚毅: "慢性関節リウマチに対する抗サイトカイン療法" 臨床と研究. 印刷中.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 新納宏昭: "IL-10による向炎症性物質の制御機構" 臨床免疫. 印刷中.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大神英一: 臨床免疫. 印刷中.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 中島衡: "確定診断のための遺伝子診断:サラセミア" 総合臨床. 48(1). 111-117 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaoka K: "Specificity of DNA binding of STAT molecules activated by IFN-g and IL-10 in human monocytes." Proceedings of the 10th International Congress of Immunology. 599-603 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大塚毅: "家族性タフトシン欠損症" 別冊日本臨床 領域別症候群シリーズ. 21. 67-69 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大塚毅: "NSAID(非ステロイド性消炎鎮痛剤)誘発性胃腸障害の対策" Pharma Medica. 16(9). 86-87 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大塚毅: "抗炎症作用を持つサイトカインによるRA制御の可能性" 医学のあゆみ. 182(9). 661-665 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大塚毅: "慢性関節リウマチ治療の新しい展開" 内科学進歩のトピックス 編集:仁保喜之、石橋大海(九州大学出版会), 3 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Niiro H: "Down regulation by IL-10 of proinflammatory molecule expression" Niho Y (ed):An Approach to Disease,-Immunology,Hematology,Oncology-Kyushu University, 10 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Niiro H,Otsuka T,Izuhara K,Yamaoka K,Ohshima K,Tanabe T,Hara S,Nemoto Y,Tanaka Y,Nakashima H,Niho Y: "Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils." Blood. 89 (5). 1621-1628 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Niiro H,Otsuka T,Ogami E,Yamaoka K,Nagano S,Akahoshi M,Nakashima H,Arinobu Y,Izuhara K,Niho Y: "MAP kinase pathways as a route for regulatory mechanisms IL-10 and IL-4 which inhibit COX-2 expression in human monocytes." Biochem Biophys Res Commun. 250 (2). 200-205 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamaoka K,Otsuka T,Niiro H,Arinobu Y,Niho Y,Hamasaki N,Izuhara K: "Activation of STAT5 by LPSthrough GM-CSF production in human monocytes." J.Immunol. 160 (2). 838-845 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nagano S,Otsuka T,Niiro H,Yamaoka K,Ohgami E,Nakashima H,Niho Y: "Increased constitutive PGE2 production by polymorphonuclear leukocytes in rheumatoid arthritis." Proceedings of the 10th International Congress of Immunology. 983-987 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tanaka Y,Nakashima H,Otsuka T,Nemoto Y,Niiro H,Yamaoka K,Ogami E,Arinobu Y,Tachida H,Imamura T,Niho Y: "Detection of polymorphisms within human IL-10 receptor cDNA gene sequence by RT-PCR-RFLP." Immunogenetics. 46. 439-441 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Asano Y,Okamura S,Ogo T,Eto T,Otsuka T,Niho Y: "Effect of (-) -epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia." Life Sciences. 60 (2). 135-142 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Otsuka T,Ogo T,Eto T,Asano Y,Suganuma M,Niho Y: "Growth inhibition of leukemic cells by (-) -epigallocatechin gallate, the main constituent of green tea." Life Sciences. 1397-1403 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Niho Y,Niiro H,Tanaka Y,Nakashima H,Otsuka T: "Role of IL-10 in the crossregulation of prostaglandins and cytokines in monocytes." Acta Haematol. 99. 165-170 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Niiro H,Otsuka T,Niho Y: "Down regulation by IL-10 of proinflammatory molecule expression." In : Niho Y (ed) : An Approach to Disease, -Immunology, Hematology, Oncology-Kyushu University Press 1-10. (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamaoka K,Otsuka T,Niiro H,Nakashima H,Ohgami E,Nagano S,Niho Y,Hamasaki N,Izuhara K: "Specificity of DNA binding of STAT molecules activated by IFN-g and IL-10 in human monocytes." Proceedings of the 10th International Congress of Immunology. 599-603 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Gao PS,Mao XQ,Jouanguy E,Nakashima H,Roberts MH,Enomoto T,Dake Y,Kawai M,Sasaki S,Shaldon SR,Coull P,Doffinger R,Pallier A,Adra CN,Otsuka T,Niho Y,Pestka S,Casanova JL,Shirakawa T,Hopkin JM: "Variants of IFNgR1 and IFNgR2 in atopic asthma." Hum.Genet. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tanaka Y,Nakashima H,Hisano C,Kohsaka T,Nemoto Y,Niiro H,Otsuka T,Otsuka T,Imamura T,Niho Y: "Association of the interferon-gamma receptor variant (Val14Met) with Systemic Lupus Erythematodes." Immunogenetics. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Arinobu Y,Sergei PA,Otsuka T: "Antagonistic effects of an alternative splice variant of human IL-4, Il-4delta2, on IL-4 activities in human monocytes and B cells." Cellular Immunology. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi